In the DreemHealth line, phytotherapeutic products are being developed as adjuvants in the treatment of respiratory diseases such as COVID-19, breast cancer, and Acute Myeloid Leukemia. We have the first transfer option for products derived from the GAT ecosystem (Colombia CientÃfica) financed by the World Bank and led by the Javeriana University
In the DreemCare line, standardized extracts are being developed as raw material for dermocosmetic products focused on skin care for patients with cancer and inflammatory pathologies, as well as Dermocosmetics with a Purpose, tasked with maintaining healthy skin.
